[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"adherence-to-glaucoma-therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:adherence-to-glaucoma-therapy":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100608828","real-world-study-to-assess-adherence-to-iop-lowering-therapy-in-glaucoma-patients-using-connectdrop-100608828",false,"NCT07206628","Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®","Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®: the GRANITE Study (Glaucoma tReatment AdhereNce wIth connecTed dEvice in Italy)","Inclusion Criteria:\n\n* Adult patient (≥ 18 years old), man or woman\n* Patient with a diagnosis of bilateral open angle glaucoma\n* Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.\n* Patient willing to participate in the study\n* Patient who consents for data collection in the frame of the study\n\nExclusion Criteria:\n\n* Pregnant and\u002For lactating woman\n* Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months)\n* Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP®\n\nThe main questions it aims to answer are:\n\n* The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient\n* The adherence profile of each patient\n* The association between the adherence profile, the objective adherence data and the clinical data.\n\nParticipants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.",[24],"Adherence to Glaucoma Therapy","RECRUITING","2025-11-14",{"date":28,"type":29},"2025-11-17","ACTUAL",{"date":31,"type":29},"2025-09-19",{"date":33,"type":20},"2027-03",{"name":35,"class":36},"Laboratoires Thea","INDUSTRY",17]